WPC
VRTX icon

Wedmont Private Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Wedmont Private Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71M Buy
3,524
+141
+4% +$62.5K 0.05% 219
2026
Q1 		$1.5M Buy
3,383
+165
+5% +$76.9K 0.05% 220
2025
Q4 		$1.56M Sell
3,218
-81
-2% -$34.9K 0.05% 200
2025
Q3 		$1.35M Sell
3,299
-1,985
-38% -$830K 0.05% 217
2025
Q2 		$2.53M Buy
5,284
+929
+21% +$428K 0.11% 114
2025
Q1 		$2.11M Buy
4,355
+722
+20% +$336K 0.11% 113
2024
Q4 		$1.49M Buy
3,633
+384
+12% +$178K 0.08% 152
2024
Q3 		$1.46M Buy
3,249
+65
+2% +$31.2K 0.08% 147
2024
Q2 		$1.56M Buy
3,184
+126
+4% +$54.7K 0.1% 125
2024
Q1 		$1.24M Buy
3,058
+213
+7% +$90K 0.09% 145
2023
Q4 		$1.19M Buy
2,845
+342
+14% +$126K 0.1% 135
2023
Q3 		$889K Buy
2,503
+235
+10% +$82.2K 0.09% 144
2023
Q2 		$800K Buy
2,268
+489
+27% +$165K 0.09% 157
2023
Q1 		$575K Sell
1,779
-131
-7% -$39.3K 0.08% 196
2022
Q4 		$554K Buy
1,910
+308
+19% +$93.9K 0.08% 187
2022
Q3 		$464K Buy
1,602
+330
+26% +$94.9K 0.09% 172
2022
Q2 		$358K Buy
1,272
+310
+32% +$83K 0.08% 195
2022
Q1 		$258K Buy
+962
New +$228K 0.06% 260

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Wedmont Private Capital's VRTX Position: Q2 2026 in Review

Wedmont Private Capital increased its Vertex Pharmaceuticals (VRTX) stake by 4.2% in Q2 2026, buying an estimated $62.5K and bringing the position to 3,524 shares worth $1.71M. The position accounts for 0.05% of the portfolio, ranked #219.

Wedmont Private Capital first reported a position in VRTX in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.53M in Q2 2025. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Wedmont Private Capital held 3,524 shares of Vertex Pharmaceuticals worth $1.71M as of Q2 2026.
  • Wedmont Private Capital bought 141 Vertex Pharmaceuticals shares in Q2 2026, an estimated $62.5K.
  • Vertex Pharmaceuticals made up 0.05% of Wedmont Private Capital's portfolio in Q2 2026, its #219 holding.
  • Wedmont Private Capital first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • Wedmont Private Capital's Vertex Pharmaceuticals position peaked at $2.53M in Q2 2025.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.